The Centers for Medicare and Medicaid Services (CMS) is pursuing a National Coverage Determination (NCD) for monoclonal antibodies that clear amyloid beta plaque from the brain, such as aducanumab ...

- Study to further assess the utility of amyloid brain PET scans for Alzheimer's Disease and other causes of cognitive decline INDIANAPOLIS, Dec. 14, 2020 /PRNewswire/ -- Eli Lilly and Company (NYSE: ...

Patient gets PET/CT scan. RadNet Inc. has become one of the first – and largest – operators of medical imaging centers to offer a cutting-edge test for brain abnormalities linked to Alzheimer’s ...

Essentia Health in Duluth now has a new tool to help diagnose Alzheimer’s, and it’s the first of its kind in the Northland. The amyloid PET Scan machine helps detect signs of the plaques that build up ...

A drug used in brain scans to help doctors detect clumps of protein associated with Alzheimer's disease was approved by the Food and Drug... Though increasingly common, Alzheimer's disease still isn't ...

Eli Lilly and Company and its wholly owned subsidiary Avid Radiopharmaceuticals Inc., have announced that Amyvid in available to imaging centres in markets surrounding 16 manufacturing sites located ...

Jan 30 (Reuters) - A Medicare advisory panel expressed skepticism on Wednesday that radioactive imaging agents like Eli Lilly and Co's Amyvid can improve health outcomes of people with early symptoms ...

Eli Lilly and Company LLY and Avid Radiopharmaceuticals, Inc., a wholly owned subsidiary of Lilly, announced today that Amyvid (Florbetapir F 18 Injection) has received marketing authorization from ...